Substituted amides, sulfonamides and ureas useful for inhibiting kinase activity

Details for Australian Patent Application No. 2007216625 (hide)

Owner Aventis Pharmaceuticals Inc

Inventors Walser, Armin; Safar, Pavel; Shimshock, Stephen J.

Agent Watermark

Pub. Number AU-B-2007216625

Parent 2002320330

Filing date 5 September 2007

Wipo publication date 27 September 2007

Acceptance publication date 2 July 2009

International Classifications

C07D 211/62 (2006.01) Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings

Event Publications

20 September 2007 Complete Application Filed

27 September 2007 Application Open to Public Inspection

  Published as AU-B-2007216625

2 July 2009 Application Accepted

  Published as AU-B-2007216625

5 November 2009 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under reg. 22.2I(2). This application has been accepted or advertised accepted. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007216626-Dismounting device

2007216624-Gaming system, server, gaming terminal and game control method